Effect of exogenous keratinocyte growth factor on corneal epithelial migration after photorefractive keratectomy☆☆☆★
Accepted 4 February 2004.
Abstract
Purpose: To investigate the effect of topical keratinocyte growth factor (KGF) on wound healing after photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK).
Setting: Department of Ophthalmology, Rayne Institute, St. Thomas' Hospital, London, United Kingdom, St. Erick's Eye Hospital, Stockholm, Sweden, and the University of Regensberg, Regensberg, Germany.
Methods: In a placebo-controlled trial, 24 New Zealand white female rabbits were divided into 3 equal groups. Group 1 (n = 8) had myopic PRK (6.0 diopters [D]) using the Technolas® 217z laser (Bausch & Lomb). Group 2 and Group 3 had myopic LASIK (6.0 D) with a flap depth of 140 μm and 180 μm, respectively. Topical KGF (20 μg/mL) was administered to half the treated eyes in each group intraoperatively and postoperatively; the other half received placebo eyedrops. Epithelial closure, corneal haze, and keratocyte activation in the rabbit eyes were analyzed and compared with those in placebo-controlled eyes for 5 weeks postoperatively.
Results: In Group 1, the mean reepithelialization after PRK was 0.10 mm2/h ± 0.02 (SD) in the KGF group and 0.33 ± 0.05 mm2/h in the control group (P = .001). There was no significant difference in the mean backscatter between the KGF eyes (154 ± 45.95) and the control eyes (141 ± 38.45) after PRK (P = .42). Histology revealed reduced epithelial cell layers in the KGF group and comparable keratocyte density as in the control group. In Groups 2 and 3, there was no significant difference in backscatter, epithelial layers, and keratocyte density between KGF and control eyes after LASIK.
Conclusions: Topical KGF (20 μg/mL) delayed reepithelialization after PRK. It had no effect on stromal wound healing in LASIK eyes with an intact epithelial barrier.
aDepartments of Ophthalmology, Rayne Institute, St. Thomas' Hospital, London, United Kingdom
cStockholm, Sweden, and the University of Regensburg, Regensburg, Germany
Reprint requests to Mr. Madhavan S. Rajan, MRCOphth, FRCS, Department of Ophthalmology, Rayne Institute, St. Thomas' Hospital, London SE17EH, United Kingdom.
☆ Supported by the Iris Fund for Prevention of Blindness, London, United Kingdom, and St. Erick's Eye Hospital, Stockholm, Sweden.
☆☆ None of the authors has a financial interest in any product mentioned.
★ Human Genome Sciences, Inc., Rockville, Maryland, USA, supplied the growth factor for the study.